Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase 2, multi-centre, randomised, vehicle-controlled clinical study
British Journal of Dermatology Oct 02, 2017
Nakagawa H, et al. - This trial substantiated the efficacy and safety of JTE-052 ointment in Japanese adult patients with atopic dermatitis (AD). The findings brought to light a rapid and significant improvement in the clinical signs and symptoms of such patients through the topical JTE-052 application. It demonstrated a favourable safety profile. Hence, topical JTE-052 served as a promising therapeutic option for AD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries